Unfortunate and costly, yes. But I admit, I was able to accumulate a good deal more shares since September.
Taking dilution into account, there should be no reason HGEN doesn’t get back into the $20’s with good top line data and on the verge of EUA, MHRA, and CMA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.